Company: MIRA
Filing Date: 2025-04-15
Form Type: 10-K/A
Source: 0001641172-25-004871
Chunk: 2

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-04-15
Form: 10-K/A
Chunk 2
---
 the voting and non-voting common equity held by non-affiliates as of June 30, 2024, was $ 2,440,211based on the closing sale price of the company’s common stock on such date of $0.64 per share, as reported by the NASDAQ Capital Market.

As of March 28, 2025, there were 16,813,654sharesof common stock, par value $ 0.0001, issued and outstanding.

<div align='center'>EXPLANATORY NOTE</div>

This Amendment No. 1 on Form 10-K/A (“Amendment”) is being filed to amend our Annual Report on Form 10-K (the “Annual Report”) for the fiscal year ended December 31, 2024 (the “Original Filing”), filed with the U.S. Securities and Exchange Commission on March 28, 2025 (the “Original Filing Date”). The sole purpose of this Amendment No. 1 is to include Exhibit 97.1 to the exhibits included in the Annual Report.

Except as described above, no changes have been made to the Original Filing and this Amendment No. 1 does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. This Amendment No. 1 does not reflect events that may have occurred subsequent to the Original Filing Date. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by the Registrant’s principal executive officer and principal financial officer are filed herewith as exhibits to this Amendment pursuant to Rule 13a-14(a) and 15d-14(a) of the Exchange Act. The Registrant is not including certifications pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) as no financial statements are being filed with this Amendment.

<div align='center'>PART IV</div>

Item 15. Exhibits, Financial Statement Schedules.

The information called for by this Item is incorporated herein by reference to the Exhibit Index in this Form 10-K/A.

| Number 
 3.1    
 3.2    |     | Description                                                                                                                                                                 
 Third                                                                                                                                                                       
 Amended and Restated Articles of Incorporation of MIRA Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 to Form S-